{"id":"https://openalex.org/W7224560671","doi":"https://doi.org/10.1158/2767-9764.crc-26-0696","title":"Anti\u2013PD-L1 glycoengineering enhances tumor killing through coordinated interactions between PD-L1\u207a DCs and CD16A\u207a cytotoxic lymphocytes","display_name":"Anti\u2013PD-L1 glycoengineering enhances tumor killing through coordinated interactions between PD-L1\u207a DCs and CD16A\u207a cytotoxic lymphocytes","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224560671","doi":"https://doi.org/10.1158/2767-9764.crc-26-0696","pmid":"https://pubmed.ncbi.nlm.nih.gov/42956317"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.crc-26-0696","doi":"https://doi.org/10.1158/2767-9764.crc-26-0696","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.crc-26-0696","pdf_url":"https://aacrjournals.org/cancerrescommun/article-pdf/doi/10.1158/2767-9764.CRC-26-0696/3845194/crc-26-0696.pdf","source":{"id":"https://openalex.org/S4210217028","display_name":"Cancer Research Communications","issn_l":"2767-9764","issn":["2767-9764"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research Communications","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacrjournals.org/cancerrescommun/article-pdf/doi/10.1158/2767-9764.CRC-26-0696/3845194/crc-26-0696.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102688237","display_name":"Anne Louise Blomberg","orcid":"https://orcid.org/0000-0002-1425-4314","observed_orcids":["https://orcid.org/0000-0002-1425-4314"]},"institutions":[{"id":"https://openalex.org/I96673099","display_name":"Technical University of Denmark","ror":"https://ror.org/04qtj9h94","country_code":"DK","type":"education","lineage":["https://openalex.org/I96673099"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Anne Louise. Blomberg","raw_affiliation_strings":["Technical University of Denmark 1 Lyngby"],"raw_orcid":"https://orcid.org/0000-0002-1425-4314","affiliations":[{"raw_affiliation_string":"Technical University of Denmark 1 Lyngby","institution_ids":["https://openalex.org/I96673099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001199496","display_name":"Weihua Tian","orcid":"https://orcid.org/0000-0003-2357-3947","observed_orcids":["https://orcid.org/0000-0003-2357-3947"]},"institutions":[{"id":"https://openalex.org/I96673099","display_name":"Technical University of Denmark","ror":"https://ror.org/04qtj9h94","country_code":"DK","type":"education","lineage":["https://openalex.org/I96673099"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Weihua Tian","raw_affiliation_strings":["Technical University of Denmark 1 Lyngby"],"raw_orcid":"https://orcid.org/0000-0003-2357-3947","affiliations":[{"raw_affiliation_string":"Technical University of Denmark 1 Lyngby","institution_ids":["https://openalex.org/I96673099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062833557","display_name":"Judit Pina Agullet","orcid":"https://orcid.org/0000-0003-1116-7693","observed_orcids":["https://orcid.org/0000-0003-1116-7693"]},"institutions":[{"id":"https://openalex.org/I96673099","display_name":"Technical University of Denmark","ror":"https://ror.org/04qtj9h94","country_code":"DK","type":"education","lineage":["https://openalex.org/I96673099"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Judit Pina. Agullet","raw_affiliation_strings":["Technical University of Denmark 1 Lyngby"],"raw_orcid":"https://orcid.org/0000-0003-1116-7693","affiliations":[{"raw_affiliation_string":"Technical University of Denmark 1 Lyngby","institution_ids":["https://openalex.org/I96673099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046415783","display_name":"Natasha Helleberg Madsen","orcid":"https://orcid.org/0000-0001-6527-8335","observed_orcids":["https://orcid.org/0000-0001-6527-8335"]},"institutions":[{"id":"https://openalex.org/I4210123737","display_name":"Bioneer (Denmark)","ror":"https://ror.org/02h8qh795","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210123737"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Natasha Helleberg. Madsen","raw_affiliation_strings":["Bioneer A/S 2 H\u00f8rsholm"],"raw_orcid":"https://orcid.org/0000-0001-6527-8335","affiliations":[{"raw_affiliation_string":"Bioneer A/S 2 H\u00f8rsholm","institution_ids":["https://openalex.org/I4210123737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160143949","display_name":"Katrine Grove. Linde","orcid":"https://orcid.org/0009-0000-6443-2169","observed_orcids":["https://orcid.org/0009-0000-6443-2169"]},"institutions":[{"id":"https://openalex.org/I96673099","display_name":"Technical University of Denmark","ror":"https://ror.org/04qtj9h94","country_code":"DK","type":"education","lineage":["https://openalex.org/I96673099"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Katrine Grove. Linde","raw_affiliation_strings":["Technical University of Denmark 1 Lyngby"],"raw_orcid":"https://orcid.org/0009-0000-6443-2169","affiliations":[{"raw_affiliation_string":"Technical University of Denmark 1 Lyngby","institution_ids":["https://openalex.org/I96673099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160109587","display_name":"Christina Psaradaki","orcid":"https://orcid.org/0009-0006-4793-0776","observed_orcids":["https://orcid.org/0009-0006-4793-0776"]},"institutions":[{"id":"https://openalex.org/I96673099","display_name":"Technical University of Denmark","ror":"https://ror.org/04qtj9h94","country_code":"DK","type":"education","lineage":["https://openalex.org/I96673099"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Christina Psaradaki","raw_affiliation_strings":["Technical University of Denmark 1 Lyngby"],"raw_orcid":"https://orcid.org/0009-0006-4793-0776","affiliations":[{"raw_affiliation_string":"Technical University of Denmark 1 Lyngby","institution_ids":["https://openalex.org/I96673099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042250606","display_name":"S\u00f8ren Skov","orcid":"https://orcid.org/0000-0003-0732-0026","observed_orcids":["https://orcid.org/0000-0003-0732-0026"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"S\u00f8ren Skov","raw_affiliation_strings":["University of Copenhagen 3 Copenhagen, Fredriksberg C"],"raw_orcid":"https://orcid.org/0000-0003-0732-0026","affiliations":[{"raw_affiliation_string":"University of Copenhagen 3 Copenhagen, Fredriksberg C","institution_ids":["https://openalex.org/I124055696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069457474","display_name":"Sarah Line Skovbakke","orcid":"https://orcid.org/0000-0002-4673-4419","observed_orcids":["https://orcid.org/0000-0002-4673-4419"]},"institutions":[{"id":"https://openalex.org/I96673099","display_name":"Technical University of Denmark","ror":"https://ror.org/04qtj9h94","country_code":"DK","type":"education","lineage":["https://openalex.org/I96673099"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Sarah Line. Skovbakke","raw_affiliation_strings":["Technical University of Denmark 1 Lyngby"],"raw_orcid":"https://orcid.org/0000-0002-4673-4419","affiliations":[{"raw_affiliation_string":"Technical University of Denmark 1 Lyngby","institution_ids":["https://openalex.org/I96673099"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076521334","display_name":"Steffen Goletz","orcid":"https://orcid.org/0000-0003-1463-5448","observed_orcids":["https://orcid.org/0000-0003-1463-5448"]},"institutions":[{"id":"https://openalex.org/I96673099","display_name":"Technical University of Denmark","ror":"https://ror.org/04qtj9h94","country_code":"DK","type":"education","lineage":["https://openalex.org/I96673099"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"Steffen Goletz","raw_affiliation_strings":["Technical University of Denmark 1 Lyngby"],"raw_orcid":"https://orcid.org/0000-0003-1463-5448","affiliations":[{"raw_affiliation_string":"Technical University of Denmark 1 Lyngby","institution_ids":["https://openalex.org/I96673099"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5076521334"],"corresponding_institution_ids":["https://openalex.org/I96673099"],"apc_list":{"value":2550,"currency":"USD","value_usd":2550},"apc_paid":{"value":2550,"currency":"USD","value_usd":2550},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.8165723,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8554999828338623,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8554999828338623,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.1145000010728836,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.011300000362098217,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.9369999766349792},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.7200000286102295},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.8659999966621399},{"id":"https://openalex.org/keywords/fcgammariiia","display_name":"Fc\u03b3RIIIa","score":0.9390000104904175},{"id":"https://openalex.org/keywords/cytotoxic-lymphocytes","display_name":"cytotoxic lymphocytes","score":0.8799999952316284},{"id":"https://openalex.org/keywords/nkt-like-cells","display_name":"NKT-like cells","score":0.902999997138977},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8109999895095825},{"id":"https://openalex.org/keywords/tumor-cell-killing","display_name":"tumor cell killing","score":0.7870000004768372},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.609000027179718}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.8795999884605408},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.7069000005722046},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5892000198364258},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5184000134468079},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49140000343322754},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48669999837875366},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.46950000524520874},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.4607999920845032},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4569000005722046},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4375},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.41190001368522644},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3984000086784363},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.38960000872612},{"id":"https://openalex.org/C2778170410","wikidata":"https://www.wikidata.org/wiki/Q506253","display_name":"Dendritic cell","level":3,"score":0.3610999882221222},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3402000069618225},{"id":"https://openalex.org/C2992881475","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T lymphocyte","level":3,"score":0.33570000529289246},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33559998869895935},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.32359999418258667},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2702000141143799},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.26100000739097595}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/2767-9764.crc-26-0696","doi":"https://doi.org/10.1158/2767-9764.crc-26-0696","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.crc-26-0696","pdf_url":"https://aacrjournals.org/cancerrescommun/article-pdf/doi/10.1158/2767-9764.CRC-26-0696/3845194/crc-26-0696.pdf","source":{"id":"https://openalex.org/S4210217028","display_name":"Cancer Research Communications","issn_l":"2767-9764","issn":["2767-9764"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research Communications","raw_type":"journal-article"},{"id":"pmid:42956317","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42956317","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research communications","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.crc-26-0696","doi":"https://doi.org/10.1158/2767-9764.crc-26-0696","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.crc-26-0696","pdf_url":"https://aacrjournals.org/cancerrescommun/article-pdf/doi/10.1158/2767-9764.CRC-26-0696/3845194/crc-26-0696.pdf","source":{"id":"https://openalex.org/S4210217028","display_name":"Cancer Research Communications","issn_l":"2767-9764","issn":["2767-9764"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research Communications","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5658641033","display_name":null,"funder_award_id":"NNF19SA0056783","funder_id":"https://openalex.org/F4320322436","funder_display_name":"Novo Nordisk"},{"id":"https://openalex.org/G7108310858","display_name":null,"funder_award_id":"NNF20SA0066621","funder_id":"https://openalex.org/F4320322436","funder_display_name":"Novo Nordisk"}],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224560671.pdf","grobid_xml":"https://content.openalex.org/works/W7224560671.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W124239641","https://openalex.org/W1820495241","https://openalex.org/W1950618346","https://openalex.org/W2046136288","https://openalex.org/W2064346335","https://openalex.org/W2084136419","https://openalex.org/W2091057822","https://openalex.org/W2100612316","https://openalex.org/W2125100264","https://openalex.org/W2129333754","https://openalex.org/W2137354517","https://openalex.org/W2161508857","https://openalex.org/W2405819699","https://openalex.org/W2604814997","https://openalex.org/W2613824844","https://openalex.org/W2734670400","https://openalex.org/W2791483720","https://openalex.org/W2801414684","https://openalex.org/W2802098245","https://openalex.org/W2883920589","https://openalex.org/W2894649513","https://openalex.org/W2913062750","https://openalex.org/W3007838533","https://openalex.org/W3039577880","https://openalex.org/W3097128992","https://openalex.org/W3103755394","https://openalex.org/W3138556548","https://openalex.org/W3187648048","https://openalex.org/W3212082453","https://openalex.org/W4224982677","https://openalex.org/W4245219291","https://openalex.org/W4283328437","https://openalex.org/W4283726248","https://openalex.org/W4297265273","https://openalex.org/W4318778538","https://openalex.org/W4319920908","https://openalex.org/W4323031408","https://openalex.org/W4327894630","https://openalex.org/W4382582401","https://openalex.org/W4387357096","https://openalex.org/W4387693232","https://openalex.org/W4393264608","https://openalex.org/W4401063685","https://openalex.org/W4409989868","https://openalex.org/W7115686752"],"related_works":["https://openalex.org/W2883920589","https://openalex.org/W4323031408","https://openalex.org/W3029598125","https://openalex.org/W3080688361","https://openalex.org/W4255130209","https://openalex.org/W4410219300","https://openalex.org/W3082234355","https://openalex.org/W2894041796","https://openalex.org/W2904491015","https://openalex.org/W2961514353"],"abstract_inverted_index":{"Blockade":[0],"of":[1,75,92],"the":[2,70],"PD-1/PD-L1":[3],"axis":[4],"has":[5],"transformed":[6],"cancer":[7,129,140],"immunotherapy,":[8],"yet":[9],"many":[10],"patients":[11],"fail":[12],"to":[13,25,138],"achieve":[14],"durable":[15],"responses.":[16],"Although":[17],"Fc":[18,132],"glycoengineering":[19,133],"by":[20,114],"defucosylation":[21],"is":[22],"well":[23],"established":[24],"enhance":[26],"NK":[27],"cell-mediated":[28],"antibody-dependent":[29],"cellular":[30],"cytotoxicity":[31],"through":[32],"increased":[33,69],"Fc\u03b3RIIIa":[34,66,98],"binding,":[35],"its":[36],"effects":[37],"on":[38,94,99],"other":[39],"Fc\u03b3RIIIa-expressing":[40],"immune":[41],"cells":[42,96],"remain":[43],"poorly":[44],"understood.":[45],"Using":[46],"complementary":[47],"human":[48,125],"in":[49,107,123],"vitro":[50],"dendritic":[51,95],"cell-lymphocyte":[52],"coculture":[53],"models,":[54,130],"we":[55],"compared":[56],"non-glycosylated,":[57],"wild-type,":[58],"and":[59,68,73,97,111,127],"defucosylated":[60,115],"anti-PD-L1":[61,116],"antibody":[62],"variants.":[63],"Defucosylation":[64],"enhanced":[65,120],"binding":[67],"relative":[71],"frequency":[72],"activation":[74,112],"cytotoxic":[76,102,108],"lymphocytes,":[77],"particularly":[78],"CD3\u207aCD56\u207a":[79],"NKT-like":[80],"cells.":[81],"Our":[82],"findings":[83],"identify":[84],"a":[85,135],"previously":[86],"unrecognized":[87],"mechanism":[88],"whereby":[89],"coordinated":[90],"engagement":[91],"PD-L1":[93],"lymphocytes":[100],"alters":[101],"lymphocyte":[103,109],"composition.":[104],"The":[105],"changes":[106],"composition":[110],"induced":[113],"were":[117],"associated":[118],"with":[119],"tumor":[121],"killing":[122],"both":[124],"2D":[126],"3D":[128],"supporting":[131],"as":[134],"potential":[136],"strategy":[137],"improve":[139],"immunotherapy.":[141]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-30T00:00:00"}